Helsinn Healthcare S.A. and Eisai Inc. Extend Relationship

9 June 2010

MonoSol Rx Announces FDA Approval of Zuplenz Oral Soluble Film for Treatment of Nausea and Vomiting

9 June 2010

Helsinn Healthcare S.A. and Eisai Inc. Extend Relationship

9 June 2010

Nautilus Neurosciences Announces U.S. Launch of CAMBIA (Diclofenac Potassium for Oral Solution) for the Treatment of Migraine

8 June 2010

EUROSTAR project 5067

31 May 2010

Helsinn and Vifor Pharma sign new contract for Gelclair in Switzerland

26 April 2010

The 5-HT3 receptor antagolist ALOXI® launched in Japan

22 April 2010

Galen Partners Invests in Nautilus Neurosciences, Inc. Funding to Provide Growth Capital for the Launch of CAMBIA™

13 April 2010

Cerbios appoints Stefano Console as Director Commercial Business Development

2 April 2010

APR Applied Pharma Research s.a. (“APR”) and Labtec GmbH (“Labtec”) announce the European Approval of Ondansetron RapidFilm™

23 March 2010